Kelly A. Kiejda-Avery

Callaghan, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Identification of a novel intergenic EPCAM-MSH2 deletion causing EPCAM-associated Lynch syndrome by long-read nanopore sequencing.

Identification of a novel intergenic EPCAM-MSH2 deletion causing EPCAM-associated Lynch syndrome by long-read nanopore sequencing.

Journal: Journal of medical genetics

Published: January 29, 2026

DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer.

DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer.

Journal: Clinical epigenetics

Published: September 19, 2025

Editorial Expression of Concern: Temozolomide induces senescence but not apoptosis in human melanoma cells.

Editorial Expression of Concern: Temozolomide induces senescence but not apoptosis in human melanoma cells.

Journal: British journal of cancer

Published: November 18, 2024

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.

Journal: The Journal of pathology

Published: July 25, 2023

It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort.

It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort.

Journal: Cancer cell international

Published: May 30, 2023

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression.

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression.

Journal: International journal of molecular sciences

Published: May 12, 2023

The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology.

The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology.

Journal: BMC health services research

Published: April 20, 2023

p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.

p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.

Journal: Cell death & disease

Published: February 28, 2023

Association of psychological distress with arm morbidity symptoms in breast cancer survivors: outcomes from the use of PHQ-9 and GAD-7 questionnaires.

Association of psychological distress with arm morbidity symptoms in breast cancer survivors: outcomes from the use of PHQ-9 and GAD-7 questionnaires.

Journal: Breast cancer (Tokyo, Japan)

Published: January 11, 2023

The role of truncated p53 isoforms in the DNA damage response.

The role of truncated p53 isoforms in the DNA damage response.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: November 13, 2022

Evaluation of Circulating MicroRNAs and Adipokines in Breast Cancer Survivors with Arm Lymphedema.

Evaluation of Circulating MicroRNAs and Adipokines in Breast Cancer Survivors with Arm Lymphedema.

Journal: International journal of molecular sciences

Published: August 08, 2022

Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.

Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.

Journal: International journal of molecular sciences

Published: May 20, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026